CD8A and neoplasm: Among these immune checkpoints, cytotoxic T-lymphocyte-associated antigen (CTLA)-4 and Tim-3 appeared to be associated with tumor antigen-specific CD8+ T-cell dysfunction in melanoma patients (37).